Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-17

Clinical Trial Update: Intranasal Dexmedetomidine vs Oral Triclofos Sodium for EEG in Children With Autism [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing intranasal dexmedetomidine to oral triclofos sodium for EEG in children with autism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • intranasal Dexmedetomidine (dexmedetomidine)
  • triclofos sodium (triclofos sodium)

Snippet

Sponsor: Rabin Medical Center | Conditions: Autistic Disorder | Phase 4 | Status: UNKNOWN